Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Neurotoxicity

Currently viewing:

Administrative data

Endpoint:
neurotoxicity: acute oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: guideline study

Data source

Referenceopen allclose all

Reference Type:
study report
Title:
Unnamed
Year:
1990
Report date:
1990
Reference Type:
publication
Title:
Neurotoxicity studies in Sprague-Dawley rats with tributyl phosphate
Author:
Healy C, Beyrouty P, Losos G, Broxup BR
Year:
1992
Bibliographic source:
Toxicologist 12, 324 (1992)
Reference Type:
publication
Title:
Acute and subchronic neurotoxicity studies with tri-n-butyl phosphate in adult Sprague-Dawley rats
Author:
Healy CE, Beyrouty PC, Broxup BR
Year:
1995
Bibliographic source:
Am Ind Hyg Assoc J 56, 349-355

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
EPA OTS 798.6050 (Neurotoxicity Screening Battery)
Principles of method if other than guideline:
Groups of 12 male and 12 female Sprague-Dawley rats were treated, by gavage, with tributyl phosphate (TBP) on a single occasion at dose levels of 100, 325 or 1000 mg/kg and then observed for 14 days. A control group was handled in an identical manner, except is was treated with the vehicle, corn oil, at the same dosage volume (10 ml/kg). The animals were examined using a functional observation battery (FOB) pre-study, at approximately 1 hour, 6 hours and 24 hours postdosing, and on observation days 7 and 14. Motor activity testing was conducted pre-study and on days 0 (approximately 11 hours following treatment), 7 and 14. Animals were subjected to a gross pathological examination at the completion of the study.
GLP compliance:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Tributyl phosphate
EC Number:
204-800-2
EC Name:
Tributyl phosphate
Cas Number:
126-73-8
Molecular formula:
C12H27O4P
IUPAC Name:
tributyl phosphate
Details on test material:
tributyl phosphate was received from FMC Corp.

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
corn oil
Analytical verification of doses or concentrations:
yes
Duration of treatment / exposure:
single treatment/ 14 d observation period
Frequency of treatment:
single treatment
Doses / concentrations
Remarks:
Doses / Concentrations:
0, 100, 325 or 1000 mg/kg bw
Basis:
nominal conc.
No. of animals per sex per dose:
12 males and 12 females
Control animals:
yes, concurrent vehicle

Results and discussion

Effect levels

Dose descriptor:
NOAEL
Effect level:
1 000 mg/kg bw/day (nominal)
Sex:
male/female
Basis for effect level:
other: NOAEL concerning neurotoxicity (single treatment/ 14 d observation period)
Remarks on result:
other:

Any other information on results incl. tables

no data

Applicant's summary and conclusion

Executive summary:

Groups of 12 male and 12 female Sprague-Dawley rats were treated, by gavage, with tributyl phosphate (TBP) on a single occasion at dose levels of 100, 325 or 1000 mg/kg and then observed for 14 days. A control group was handled in an identical manner, except is was treated with the vehicle, corn oil, at the same dosage volume (10 ml/kg). The animals were examined using a functional observation battery (FOB) pre-study, at approximately 1 hour, 6 hours and 24 hours postdosing, and on observation days 7 and 14. Motor activity testing was conducted pre-study and on days 0 (approximately 11 hours following treatment), 7 and 14. Animals were subjected to a gross pathological examination at the completion of the study.

Dosages of 325 and 1000 mg/kg resulted in transient clinical changes and 1000 mg/kg resulted in transient decreases in male body weights, forelimb gripstrengh and motor activity levels for both sexes. The pattern of effects seen was attributed to an acute, non-specific toxicity without apparent neurotoxicity. No gross pathological findings were seen indicative of a treatment-related effect.